Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 29pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US6147191: Oligodendrocyte-specific protein
[ Derwent Title ]
>> View Certificate of Correction for this publication


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
29 pages

 
Inventor: Seitz, Robert S.; Huntsville, AL
Lallone, Roger L.; Birmingham, AL
Bronstein, Jeff M.; Santa Monica, CA

Assignee: The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
 News, Profiles, Stocks and More about this company

Published / Filed: 2000-11-14 / 1998-05-26

Application Number: US1998000084153

IPC Code: Advanced: C07K 14/47; C07K 16/18; A61K 38/00;
Core: C07K 14/435; more...
IPC-7: C07K 1/00;

ECLA Code: C07K14/47A5; C07K16/18;

U.S. Class: Current: 530/350;
Original: 530/350;

Field of Search: 530/350

Government Interest:

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
    This invention was made with Government support under Grant No. NS01596, awarded by the National Institutes of Health. The Government has certain rights in this invention.

Priority Number:
1998-05-26  US1998000084153
1995-11-14  US1995000557917

Abstract: A protein consisting essentially of purified oligodendrocyte-specific protein or purified biologically active variants thereof, or a combination of purified oligodendrocyte-specific protein and biologically active variants thereof. A purified and isolated peptide having the sequence Ala-Lys-Tyr-Arg-Arg-Ala-Gln-Leu-Ala-Gly, residues 115-124 of SEQ ID NO:2. A device for identifying an epitope region of a peptide, protein, or protein homologue of interest comprising a polypropylene membrane having a plurality of sequentially oriented peptide spots, each spot containing a peptide having an amino acid sequence where the amino acid sequences of the peptides on the peptide spots sequentially progress through the amino acid sequence of the peptide, protein, or protein homologue of interest. A method of diagnosing multiple sclerosis and a method of treating multiple sclerosis. A method of diagnosing a disease or condition, such as an autoimmune disease, the disease or condition having the clinical feature of antibody production against a peptide, protein, or protein homologue.

Attorney, Agent or Firm: Farah, David A.Sheldon & Mak ;

Primary / Asst. Examiners: Caputa, Anthony C.; Navarro, Mark

Maintenance Status: E1 Expired  Check current status
CC Certificate of Correction issued
View Certificate of Correction

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

       
Related Applications:
Application Number Filed Patent Pub. Date  Title
US1995000557917 1995-11-14    1998-05-26  Oligodendrocyte-specific protein and method for diagnosing and treating disease


       
Parent Case:

CROSS-REFERENCE TO RELATED APPLICATIONS
    This Application is a divisional of U.S. patent application Ser. No. 08/557,917, entitled OLIGODENDROCYTE-SPECIFIC PROTEIN AND METHOD FOR law DIAGNOSING AND TREATING DISEASE and filed Nov. 14, 1995 now U.S. Pat. No. 5,756,300.

Designated Country: AL AM AP AT AZ BA BB BG BR BY CA CH CN CU CZ DK EE FI GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT  DE ES FR GB IT 

Family: Show 7 known family members

First Claim:
Show all 8 claims
We claim:     1. A protein consisting essentially of purified oligodendrocyte-specific protein having an amino acid sequence as set forth in SEQ ID NO: 2.

Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

       
U.S. References: Go to Result Set: All U.S. references   |  No patents reference this one   |   Backward references (9)   |   Citation Link

Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 10pp US4396601  1983-08 Salser et al.  The Regents of the University of Calif. Gene transfer in intact mammals
Buy PDF- 15pp US4708871  1987-11 Geysen  Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
Buy PDF- 15pp US4923901  1990-05 Koester et al.  Millipore Corporation Membranes with bound oligonucleotides and peptides
Buy PDF- 3pp US4994466  1991-02 Sherman et al.  Baker Cummins Pharmaceuticals, Inc. Method of treatment for multiple sclerosis
Buy PDF- 9pp US5112810  1992-05 Nagai et al.  Mitsui Pharmaceuticals, Inc. Method for treating multiple sclerosis
Buy PDF- 19pp US5130297  1992-07 Sharma et al.  Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
Buy PDF- 7pp US5188733  1993-02 Wang et al.  Trustees of Boston University Apparatus and process for effecting sequential peptide syntheses
Buy PDF- 37pp US5194425  1993-03 Sharma et al.  Anergen, Inc. MHC-mediated toxic conjugates useful in ameliorating autoimmunity
Buy PDF- 27pp US5756300  1998-05 Seitz et al.  Research Genetics, Inc. Oligodendrocyte-specific protein and method for diagnosing and treating disease
       
Foreign References:
Buy
PDF
Publication Date IPC Code Assignee   Title
Buy PDF- 27pp WO9215884 1992-09  C07K 14/435 THE UAB RESEARCH FOUNDATION NOVEL PROTEIN, METHOD AND PRODUCTS FOR DETECTION OF OLIGODENDROCYTES 
Buy PDF- 69pp WO9717984 1997-05  A61K 38/00 BRONSTEIN, JEFF, M. OLIGODENDROCYTE-SPECIFIC PROTEIN AND METHOD FOR TREATING DISEASE 


Other Abstract Info: CHEMABS 134(01)001358V DERABS C1997-289056 DERABS C2001-040476

Other References:
  • Buznikov, A. et al., "Cloning Of The Human Oligodendrocyte-Specific Protein (OSP) Homologue," Dept. Of Neurology And Pharmacology And The Brain Research Institute, UCLA School of Medicine, Los Angeles, CA-Abstract and Poster From Society For Neuroscience Meeting, Nov. of 1996.
  • Pham-Dinh, D. et al., "Characterization and Expression of the cDNA Coding for the Human Myelin/Oligodendrocyte Glycoprotein," Journal of Neurochemistry, 63(6);2353-2356 (1994). (4 pages) Cited by 5 patents [ISI abstract]
  • Schaeren-Wiemers, N. et al., "Identification of New Oligodendrocyte- and Myelin-Specific Genes by a Differential Screening Approach," Journal Of Neurochemistry, 65(1):10-22, 1995. (13 pages) Cited by 2 patents [ISI abstract]
  • Schaefer et al., "The C-DNA of COP, A novel oligodendrocyte-specific protein," Experientia, 49:A66 (1993).
  • Sevier, E.D. et al., "Monoclonal Antibodies in Clinical Immunology," Clinical Chemistry, 27(11):1797-1805 (1981). (10 pages) Cited by 283 patents
  • Xie, D. et al., "The oligodendroglial reaction to brain stab wounds: an immunohistochemical study," Journal Of Neurocytology, 24:435-448 (1995). (14 pages) Cited by 3 patents [ISI abstract]


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help